[go: up one dir, main page]

NO20014806L - Kombinasjonspreparat for behandling av malaria - Google Patents

Kombinasjonspreparat for behandling av malaria

Info

Publication number
NO20014806L
NO20014806L NO20014806A NO20014806A NO20014806L NO 20014806 L NO20014806 L NO 20014806L NO 20014806 A NO20014806 A NO 20014806A NO 20014806 A NO20014806 A NO 20014806A NO 20014806 L NO20014806 L NO 20014806L
Authority
NO
Norway
Prior art keywords
treatment
malaria
combination preparation
proguanil
primaquine
Prior art date
Application number
NO20014806A
Other languages
English (en)
Norwegian (no)
Other versions
NO20014806D0 (no
Inventor
Jeffrey David Chulay
Original Assignee
Glaxo Group Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Glaxo Group Ltd filed Critical Glaxo Group Ltd
Publication of NO20014806D0 publication Critical patent/NO20014806D0/no
Publication of NO20014806L publication Critical patent/NO20014806L/no

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/12Ketones
    • A61K31/122Ketones having the oxygen directly attached to a ring, e.g. quinones, vitamin K1, anthralin
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/13Amines
    • A61K31/155Amidines (), e.g. guanidine (H2N—C(=NH)—NH2), isourea (N=C(OH)—NH2), isothiourea (—N=C(SH)—NH2)
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/33Heterocyclic compounds
    • A61K31/395Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/47Quinolines; Isoquinolines
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P33/00Antiparasitic agents
    • A61P33/02Antiprotozoals, e.g. for leishmaniasis, trichomoniasis, toxoplasmosis
    • A61P33/06Antimalarials
    • YGENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y02TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
    • Y02ATECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE
    • Y02A50/00TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE in human health protection, e.g. against extreme weather
    • Y02A50/30Against vector-borne diseases, e.g. mosquito-borne, fly-borne, tick-borne or waterborne diseases whose impact is exacerbated by climate change

Landscapes

  • Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Epidemiology (AREA)
  • Tropical Medicine & Parasitology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
NO20014806A 1999-04-09 2001-10-03 Kombinasjonspreparat for behandling av malaria NO20014806L (no)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US12867299P 1999-04-09 1999-04-09
PCT/US2000/009091 WO2000061133A1 (fr) 1999-04-09 2000-04-05 Preparation combinee a utiliser pour le traitement de la malaria

Publications (2)

Publication Number Publication Date
NO20014806D0 NO20014806D0 (no) 2001-10-03
NO20014806L true NO20014806L (no) 2001-12-05

Family

ID=22436426

Family Applications (1)

Application Number Title Priority Date Filing Date
NO20014806A NO20014806L (no) 1999-04-09 2001-10-03 Kombinasjonspreparat for behandling av malaria

Country Status (23)

Country Link
US (1) US6413993B1 (fr)
EP (1) EP1171108B1 (fr)
JP (1) JP2002541196A (fr)
KR (1) KR100613805B1 (fr)
CN (1) CN1152676C (fr)
AT (1) ATE241971T1 (fr)
AU (1) AU758167B2 (fr)
BR (1) BR0009676A (fr)
CA (1) CA2369089A1 (fr)
CZ (1) CZ294903B6 (fr)
DE (1) DE60003175T2 (fr)
DK (1) DK1171108T3 (fr)
ES (1) ES2199817T3 (fr)
HU (1) HUP0200842A3 (fr)
IL (2) IL145609A0 (fr)
MX (1) MXPA01010125A (fr)
NO (1) NO20014806L (fr)
NZ (1) NZ514353A (fr)
PL (1) PL350987A1 (fr)
PT (1) PT1171108E (fr)
TR (1) TR200102843T2 (fr)
WO (1) WO2000061133A1 (fr)
ZA (1) ZA200108254B (fr)

Families Citing this family (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB9224739D0 (en) * 1992-11-26 1993-01-13 Wellcome Found Medicaments
KR20110010763A (ko) * 2008-05-09 2011-02-07 톨마 인코포레이티드 피부/점막 질환을 치료하기 위한 프로구아닐
EP2318350A4 (fr) * 2008-07-25 2012-11-28 Alphapharm Pty Ltd ATOVAQUONE À DIAMÈTRE DE PARTICULES (D90) VARIANT DE PLUS DE 3 muM À ENVIRON 10 muM
WO2011021230A2 (fr) * 2009-08-20 2011-02-24 Ipca Laboratories Limited Nouveau complexe pour le traitement et/ou la prophylaxie d'infections parasitaires
CN108697706B (zh) * 2016-02-12 2021-07-16 花王株式会社 黑色素分解抑制剂
KR102637575B1 (ko) * 2016-10-05 2024-02-20 타이탄 파머슈티컬즈 인코퍼레이티드 버스트 방출이 감소된 약물 전달용 이식 가능한 장치
US20200155481A1 (en) * 2017-05-03 2020-05-21 The Johns Hopkins University Intramuscular atovaquone for malaria prophylaxis
CN107737108B (zh) * 2017-12-17 2018-06-26 姚蕾 一种治疗心肌梗死后心室重塑的口服药物组合物

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB9224739D0 (en) * 1992-11-26 1993-01-13 Wellcome Found Medicaments
JPH0873355A (ja) * 1994-09-02 1996-03-19 Mitsui Toatsu Chem Inc 抗マラリア薬耐性克服剤

Also Published As

Publication number Publication date
IL145609A (en) 2006-04-10
DE60003175T2 (de) 2004-04-01
EP1171108A1 (fr) 2002-01-16
NO20014806D0 (no) 2001-10-03
CN1152676C (zh) 2004-06-09
HUP0200842A3 (en) 2006-07-28
IL145609A0 (en) 2002-06-30
MXPA01010125A (es) 2002-06-04
PT1171108E (pt) 2003-10-31
CN1346267A (zh) 2002-04-24
KR100613805B1 (ko) 2006-08-18
US6413993B1 (en) 2002-07-02
BR0009676A (pt) 2002-09-03
HK1041638A1 (en) 2002-07-19
ZA200108254B (en) 2003-03-26
DE60003175D1 (de) 2003-07-10
CA2369089A1 (fr) 2000-10-19
AU758167B2 (en) 2003-03-20
ES2199817T3 (es) 2004-03-01
WO2000061133A1 (fr) 2000-10-19
JP2002541196A (ja) 2002-12-03
CZ294903B6 (cs) 2005-04-13
CZ20013646A3 (cs) 2002-06-12
TR200102843T2 (tr) 2002-01-21
PL350987A1 (en) 2003-02-24
KR20010108468A (ko) 2001-12-07
ATE241971T1 (de) 2003-06-15
DK1171108T3 (da) 2003-10-06
AU4202200A (en) 2000-11-14
EP1171108B1 (fr) 2003-06-04
HUP0200842A2 (hu) 2002-07-29
NZ514353A (en) 2003-10-31

Similar Documents

Publication Publication Date Title
GEP20053602B (en) Aripiprazole for Oral Administration
DK0998287T3 (da) Anvendelse af levobupivacain
CY1106602T1 (el) Παραγωγα αδαμαντανιου για τη θεραπεια φλεγμονωδων, ανοσολογικων και καρδιαγγειακων ασθενειων
EA200301165A1 (ru) Лекарственное средство на основе оксикодона
NZ516349A (en) Conjugates of phytosterol or phytostanol with ascorbic acid and use thereof in treating or preventing cardiovascular disease
AU1167602A (en) Methods of therapy for hiv infection
NO20014806D0 (no) Kombinasjonspreparat for behandling av malaria
EE05241B1 (et) Distamtsiini a-halogenoakrlolderivaadi kasutamine
WO2001000231A3 (fr) Vaccins
AP9400647A0 (en) Medicaments for use in treatment of HIV or cancer patients.
USD467344S1 (en) Treatment couch
ATE452654T1 (de) Polyalkylenoxid-konjugate von thiolhaltigen arzneistoffen
DK1150981T3 (da) Terapeutisk necleosidforbindelse
EP1143981A4 (fr) Traitement et prevention d'infections par le vih et d'autres infections virales
MXPA03010920A (es) Uso de alconil l- carnitina para preparacion de medicamento para tratar anhedonia.
MXPA03010919A (es) Uso de acetil l-carnitina para preparacion de medicamento para terapia preventiva del dolor.
PT1670846E (pt) Copolímeros de éster 1-vinilpirrolidina-2-one
IL139064A0 (en) Intermittent claudication therapeutic drugs comprising pyrroloazepines
WO2003059334A3 (fr) Gemcitabine pour traiter la variole
AU2002328253A1 (en) Pna conjugate for the treatment of diseases associated with hiv
UA32280A (uk) Спосіб формування тонко-товстокишкового анастомозу бік у бік
RU2002115585A (ru) Способ профилактики тромбоза и инфицирования катетера, находящегося в магистральной вене
UA38042A (uk) Протифібриляторний препарат трамадол
AU2002308925A1 (en) Blood group-free human blood plasma and the preparation method thereof
EP1383563A4 (fr) Methodes de traitement du vih et d'autres virus

Legal Events

Date Code Title Description
FC2A Withdrawal, rejection or dismissal of laid open patent application